Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
Current assets:    
Cash and cash equivalents $ 14,498 $ 17,528
Accounts receivable, net of allowance for doubtful accounts of $585 and $500 at October 31, 2022 and January 31, 2022, respectively 7,011 8,819
Unbilled receivables, net 9,350 9,160
Prepaid expenses and other current assets 2,545 2,310
Total current assets 33,404 37,817
Property and equipment, net 686 902
Operating lease right-of-use assets 1,392 2,031
Goodwill   9,882
Unbilled receivables, net 2,680 3,952
Other assets 404 612
Total assets 38,566 55,196
Current liabilities:    
Accounts payable 3,529 2,960
Accrued expenses 2,825 4,217
Deferred revenue 2,507 3,947
Total current liabilities 8,861 11,124
Deferred revenue 47 77
Operating lease liabilities 787 1,361
Taxes payable 98 110
Other liabilities 3  
Total liabilities 9,796 12,672
Commitments and contingencies (Note 5)
Stockholders' equity:    
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 50,361,378 shares issued and 50,189,458 shares outstanding at October 31, 2022; 49,347,604 shares issued and 49,175,684 shares outstanding at January 31, 2022 503 493
Additional paid-in capital 266,352 265,644
Treasury stock, at cost; 171,920 shares at October 31, 2022 and January 31, 2022 (227) (227)
Accumulated other comprehensive loss (2,314) (973)
Accumulated deficit (235,544) (222,413)
Total stockholders' equity 28,770 42,524
Total liabilities and stockholders' equity $ 38,566 $ 55,196